Wolf Judith K相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Evaluation of pegylated liposomal doxorubicin dose on the adverse drug event profile and outcomes in treatment of recurrent endometrial cancer

评估聚乙二醇化脂质体阿霉素剂量对复发性子宫内膜癌治疗中不良药物事件特征和疗效的影响

期刊:International Journal of Gynecological Cancer

影响因子:4.7

doi:10.1097/IGC.0b013e31827c18f3

Julius, Justin M; Tanyi, Janos L; Nogueras-Gonzalez, Graciela M; Watkins, Jack L; Coleman, Robert L; Wolf, Judith K; Smith, Judith A

子宫内膜癌

发表日期：2013

文献求助收藏

Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer.

培利福新联合多西他赛治疗铂类和紫杉烷类耐药或难治性高级别上皮性卵巢癌患者

期刊:Gynecologic Oncology

影响因子:4.1

doi:10.1016/j.ygyno.2012.04.006

Fu Siqing, Hennessy Bryan T, Ng Chaan S, Ju Zhenlin, Coombes Kevin R, Wolf Judith K, Sood Anil K, Levenback Charles F, Coleman Robert L, Kavanagh John J, Gershenson David M, Markman Maurie, Dice Kristine, Howard Adrienne, Li Jane, Li Yang, Stemke-Hale Katherine, Dyer Mary, Atkinson Edward, Jackson Ed, Kundra Vikas, Kurzrock Razelle, Bast Robert C Jr, Mills Gordon B

发表日期：2012

文献求助收藏

Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer

一项 1b-2a 期研究旨在通过使用低甲基化药物阿扎胞苷逆转铂类耐药性，治疗铂类耐药或铂类难治性上皮性卵巢癌患者。

影响因子:5.1

doi:10.1002/cncr.25701

Fu, Siqing; Hu, Wei; Iyer, Revathy; Kavanagh, John J; Coleman, Robert L; Levenback, Charles F; Sood, Anil K; Wolf, Judith K; Gershenson, David M; Markman, Maurie; Hennessy, Bryan T; Kurzrock, Razelle; Bast, Robert C Jr

发表日期：2011

文献求助收藏

Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial

吉西他滨联合顺铂治疗子宫内膜癌女性患者疗效显著：一项前瞻性 II 期试验的结果

影响因子:5.1

doi:10.1002/cncr.25498

Brown, Jubilee; Smith, Judith A; Ramondetta, Lois M; Sood, Anil K; Ramirez, Pedro T; Coleman, Robert L; Levenback, Charles F; Munsell, Mark F; Jung, Maria; Wolf, Judith K

子宫内膜癌

发表日期：2010

文献求助收藏

BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas

BRAF突变在晚期低级别卵巢浆液性癌中较为罕见。

期刊:American Journal of Pathology

影响因子:3.6

doi:10.2353/ajpath.2010.100212

Wong, Kwong-Kwok; Tsang, Yvonne T M; Deavers, Michael T; Mok, Samuel C; Zu, Zhifei; Sun, Charlotte; Malpica, Anais; Wolf, Judith K; Lu, Karen H; Gershenson, David M

发表日期：2010

文献求助收藏

PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas

PAX2在低恶性潜能卵巢肿瘤和低级别卵巢浆液性癌中的表达

期刊:Modern Pathology

影响因子:5.5

doi:10.1038/modpathol.2009.92

Tung, Celestine S; Mok, Samuel C; Tsang, Yvonne T M; Zu, Zhifei; Song, Huijuan; Liu, Jinsong; Deavers, Michael T; Malpica, Anais; Wolf, Judith K; Lu, Karen H; Gershenson, David M; Wong, Kwong-Kwok

发表日期：2009

文献求助收藏